Insulet Corporation
PODD Healthcare Medical Devices
Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow PODD
Insulet Corporation (PODD) Current ratio
Insulet Corporation's current ratio at the end of the quarter to 30 June 2026 was 2.5×, down 0.3× from fiscal 2025 (2.8×). Over the past ten years it has ranged from 2.8× (fiscal 2025) to 6.6× (fiscal 2016) — the current reading is the lowest in ten years. That is in line with the Medical Devices industry median of 2.5× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 2.8× | (21.37%) |
| FY2024 | 3.6× | 2.03% |
| FY2023 | 3.5× | (2.63%) |
| FY2022 | 3.6× | (38.01%) |
| FY2021 | 5.8× | (3.28%) |
| FY2020 | 6.0× | 60.35% |
| FY2019 | 3.7× | (6.00%) |
| FY2018 | 4.0× | (36.15%) |
| FY2017 | 6.2× | (5.99%) |
| FY2016 | 6.6× | 126.87% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 2.5× | (0.07%) |
| Mar 2026 | 2.5× | (11.65%) |
| Dec 2025 | 2.8× | (1.97%) |
| Sep 2025 | 2.9× | 27.20% |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| PEN Penumbra, Inc. compare | 5.7× |
| GKOS Glaukos Corporation compare | 5.0× |
| GMED Globus Medical, Inc. compare | 4.6× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 3.1× |
| BIO Bio-Rad Laboratories, Inc. compare | 3.1× |
| HAE Haemonetics Corporation compare | 3.1× |
| PODD Insulet Corporation | 2.5× |
| SNN Smith & Nephew SNATS, Inc. compare | 2.1× |
| BRKR Bruker Corporation compare | 1.8× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on PODD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement